EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
This Quarter Return
-17.08%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$1.72B
AUM Growth
+$1.72B
(-24%)
Cap. Flow
-$107M
Cap. Flow
% of AUM
-6.21%
Top 10 Holdings %
Top 10 Hldgs %
20.3%
Holding
982
New
34
Increased
135
Reduced
119
Closed
36
Top Buys
| 1 |
Marriott International Class A Common Stock
MAR
|
$13.5M |
| 2 |
IQVIA
IQV
|
$13M |
| 3 |
Darden Restaurants
DRI
|
$12M |
| 4 |
Gilead Sciences
GILD
|
$7.13M |
| 5 |
Coterra Energy
CTRA
|
$6.7M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
$29.9M |
| 2 |
Biogen
BIIB
|
$28.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
$24.2M |
| 4 |
CVS Health
CVS
|
$23.2M |
| 5 |
AMRN
Amarin Corp
AMRN
|
$20.9M |
Sector Composition
| 1 | Healthcare | 27.96% |
| 2 | Technology | 23.65% |
| 3 | Consumer Discretionary | 13.13% |
| 4 | Financials | 9.02% |
| 5 | Communication Services | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.77T
| $72.1M | 4.19% | 454,177 -105,720 | -19% | -$16.8M |
|
2
Sarepta Therapeutics
SRPT
$1.78B
| $41.8M | 2.43% | 426,260 -144,000 | -25% | -$14.1M |
|
3
Agios Pharmaceuticals
AGIO
$2.19B
| $36.7M | 2.14% | 1,035,400 -43,300 | -4% | -$1.54M |
|
4
Alphabet (Google) Class A
GOOGL
$2.57T
| $31M | 1.8% | 27,127 -52 | -0.2% | -$59.5K |
|
5
Meta Platforms (Facebook)
META
$1.86T
| $29.6M | 1.72% | 178,085 +27 | +0% | +$4.49K |
|
|
6
Biogen
BIIB
$19.4B
| $29.3M | 1.7% | 93,067 -90,140 | -49% | -$28.3M |
|
7
Silicon Motion
SIMO
$2.71B
| $27.7M | 1.61% | 754,680 +67,900 | +10% | +$2.49M |
|
8
BioMarin Pharmaceuticals
BMRN
$11.2B
| $27.5M | 1.6% | 328,200 -111,700 | -25% | -$9.37M |
|
9
Alibaba
BABA
$322B
| $27.1M | 1.58% | 141,769 +24,021 | +20% | +$4.59M |
|
10
Visa
V
$683B
| $26.1M | 1.52% | 158,904 -13,010 | -8% | -$2.14M |
|
11
Apple
AAPL
$3.45T
| $24.5M | 1.42% | 96,412 -2,885 | -3% | -$733K |
|
12
Texas Roadhouse
TXRH
$11.5B
| $24.1M | 1.4% | 584,262 +576 | +0.1% | +$23.8K |
|
|
13
Gilead Sciences
GILD
$140B
| $23.7M | 1.38% | 314,205 +94,495 | +43% | +$7.13M |
|
14
Starbucks
SBUX
$100B
| $22.6M | 1.31% | 342,656 -75,144 | -18% | -$4.95M |
|
15
Adobe
ADBE
$151B
| $22.3M | 1.3% | 70,641 -7,118 | -9% | -$2.25M |
|
16
Vertex Pharmaceuticals
VRTX
$100B
| $21.2M | 1.23% | 91,400 +9,500 | +12% | +$2.2M |
|
17
iShares MSCI Emerging Markets ETF
EEM
$19B
| $19.6M | 1.14% | 573,018 -5,200 | -0.9% | -$177K |
|
18
LKQ Corp
LKQ
$8.39B
| $19.4M | 1.13% | 943,800 | – | – |
|
19
Mastercard
MA
$538B
| $17M | 0.99% | 67,360 -2,662 | -4% | -$673K |
|
20
Intel
INTC
$107B
| $16.8M | 0.98% | 306,423 +36,542 | +14% | +$2M |
|
21
SPDR S&P 500 ETF Trust
SPY
$658B
| $16.7M | 0.97% | 64,749 -9,035 | -12% | -$2.33M |
|
22
ON Semiconductor
ON
$20.3B
| $15.7M | 0.91% | 1,262,460 -45,000 | -3% | -$560K |
|
|
23
IQVIA
IQV
$32.4B
| $15.7M | 0.91% | 144,699 +119,639 | +477% | +$13M |
|
24
Bath & Body Works
BBWI
$6.18B
| $15M | 0.88% | 1,301,000 -485,000 | -27% | -$5.61M |
|
25
iShares Core S&P 500 ETF
IVV
$662B
| $15M | 0.87% | 58,190 -14,910 | -20% | -$3.85M |
|